Document is current
Any future updates will be listed below
-
Authors
Fischer, Sebastian
Koller, Lena
Dominelli, Sandra
Beck, Roswitha
Wester, Hans-Jürgen
Günther, Thomas https://orcid.org/0000-0002-7412-0297
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG - 68647618)
Technische Universität München
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 6 April 2025
First Online: 1 September 2025
Declarations
:
: Nothing to declare.
: Nothing to declare.
: A patent application on modified GRPR-targeted antagonists with H.-J.W. and T.G. as co-inventors has been filed. H.-J.W. is founder and shareholder of Scintomics GmbH, Munich, Germany. No other potential conflicts of interest relevant to this article exist.
